Additionally, Zhu et al. [38] found that silencing neuropilin-1 (NRP-1) partially reverses TGF-β1-induced EMT in COAD cells, leading to reduced proliferation and migration, highlighting NRP-1 as a promising therapeutic target. This evidence concerns the gene TGFB1 and colon adenocarcinoma.